The nuchal translucency screening is performed via ultrasound. Conception is often compared to a roll of the dice. You hope for a particular outcome but know that your success depends a great deal on ...

“Prenatal testing can be a very important and emotional decision for parents,” Dr. Wick says. “If the infant has a lethal condition, discussion should include monitoring during labor (for example, a ...

NEW YORK (Reuters Health) - Normally, parents who want to know the sex of their baby before it's born find out through ultrasound done in the second trimester. A blood test that can be done early in ...

The NIPT (noninvasive prenatal testing) is a genetic test performed on pregnant women, in order to detect fetal chromosomal aneuploidies. It is based upon the testing of cell-free fetal DNA (cf-fDNA) ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenatal ...

Please can you give an overview of the causes of preterm labor. Preterm birth is the most significant issue facing pregnant women and the clinicians caring for them. With each preterm delivery, a ...

Would you want to know if your unborn baby is at risk of autism? Researchers wrapping up a 4,406-patient study say that a new genetic test that analyzes fetal DNA in more detail than current prenatal ...

LONDON - JULY 18: (Photo illustration by Daniel Berehulak/Getty Images) Over time, non-invasive screening studies were developed that were easier and safer for pregnant patients. Early versions of ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

Add Yahoo as a preferred source to see more of our stories on Google. During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or ...

A disturbing report from The New York Times on the unreliability of prenatal blood testing for genetic abnormalities should do more than make us wish that the testing companies were better regulated.